After guiding UBS Group (UBS) through one of the biggest banking rescues in Europe, Chief Executive Officer Sergio Ermotti is expected to step aside in April 2027, according to a Financial Times report. The timing aligns with UBS’s goal to finish most of the Credit Suisse integration by the end of 2026.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Reportedly, Aleksandar Ivanovic, UBS’s head of asset management, is among the leading internal candidates to succeed Ermotti. Other executives previously named as possible contenders include Robert Karofsky, Asia-Pacific head Iqbal Khan, and Chief Operating Officer Bea Martin, who was appointed last year.
Ermotti’s Second Term Nears Its End
Ermotti previously led UBS from 2011 to 2020 and then returned as CEO in 2023 to manage the emergency takeover of Credit Suisse after the bank’s collapse. His return was widely viewed as a stabilizing move, given his role in rebuilding UBS after the global financial crisis.
Last year, Ermotti said he would remain in the role until at least the end of 2026 or early 2027 to see the integration through. A planned exit in April 2027 would follow that timeline and suggest a smooth handover rather than an abrupt change.
UBS Stock Gained under Ermotti’s Leadership
UBS shares have performed strongly during Ermotti’s second stint. The stock has climbed nearly 50% over the past year and has more than doubled since the bank agreed to acquire Credit Suisse, reflecting investor confidence in the integration process and UBS’s long-term strategy.
The bank has also reinforced its position as a global wealth management leader while working to cut costs and reduce risks tied to the Credit Suisse deal.
Is UBS Stock a Buy or a Sell Now?
Turning to Wall Street, UBS stock has a Moderate Buy consensus rating based on eight Buys and two Holds assigned in the last three months. At $46, the average UBS price target implies a 3.93% downside potential.
